Duovir N 150 mg/200 mg/300 mg (Lamivudine/Zidovudine/Nevirapine) Quantity:30 Tablet/s Stopping treatment usually reverses effect

Stopping treatment usually reverses effect within 12 months

Elderly patients can use Aldactone but may require dose adjustments and closer monitoring due to increased sensitivity and risk of side effects

injection‑site pain

For a comprehensive understanding of cabergoline's mechanism

providing a synergistic approach that reduces the likelihood of viral resistance

Duovir N 150 mg/200 mg/300 mg (Lamivudine/Zidovudine/Nevirapine) Quantity:30 Tablet/s Stopping treatment usually reverses effectProduct Overview Duovir N 150 mg 200 mg 300 mg (Lamivudine Zidovudine Nevirapine) is a fixeddose combination antiretroviral therapy (ART) manufactured by Cipla Limited. The product is supplied in a bottle containing 30 tablets and is indicated for the treatment of HIV infection in adults. Each tablet delivers a specific dose of three active agents that work synergistically to suppress viral replication, improve immune function, and delay disease